cancer of unknown primary

Mar 11, 2020

Microbiome-Based Cancer Dx Emerges From Cancer Genome Atlas Reanalysis

Feb 19, 2020

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

Nov 6, 2019

Merck, Promega Collaborate to Develop MSI CDx for Keytruda

Aug 16, 2019

Foundation Medicine to Seek FDA Approval for FoundationOne as CDx to Genentech's Rozlytrek

Jul 24, 2019

Dx Uses Cancer Cells' Electrical Properties to Measure Efficacy of Chemotherapy
Premium

Apr 16, 2019

Cancer Genetics Q4 Revenues Down 9 Percent

Mar 12, 2019

Guardant Health Q4 Revenues Up 64 Percent

Oct 9, 2018

JP Morgan Initiates Coverage of Natera at Neutral

Sep 12, 2018

Epic Sciences Raises $52M in Series E Financing

Jul 25, 2018

Xiamen Spacegen Receives CE Marking for Six Molecular Testing Kits

May 9, 2018

Mammoth Biosciences Developing CRISPR-Based Disease Detection for At-Home, Hospital Use
Premium

Mar 29, 2018

Institut Curie to Evaluate Freenome AI Platform for Analyzing cfDNA in Cancer Patients

Mar 8, 2018

Improvements Move Broad's CRISPR-Based Diagnostic Technology Closer to Field, Clinic
Premium

Jan 26, 2018

CanHelp Pushes Gene Expression Tests Toward Clinical Approval in China
Premium

Nov 14, 2017

MolecularMD to Offer Promega Microsatellite Instability Technology

Oct 16, 2017

BioSequence Commences Clinical Trial of OncoDNA's Cancer of Unknown Primary Test
Premium

Dec 6, 2016

ClearLight Diagnostics Raises $3.5M in Series B Funding

Sep 29, 2016

Agilent Technologies, Burning Rock Collaborate on Cancer Diagnostics for China